Insider Transactions in Q1 2022 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.17%
|
$40,000
$4.8 P/Share
|
|
Feb 18
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.67%
|
$200,000
$5.0 P/Share
|
|
Feb 03
2022
|
Antony C. Mattessich President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
186,750
+39.2%
|
-
|
|
Feb 03
2022
|
Michael H. Goldstein President, Ophthalmology & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
63,333
+16.81%
|
-
|
|
Feb 03
2022
|
Christopher G White Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.96%
|
-
|
|
Feb 03
2022
|
Philip C. Strassburger General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.11%
|
-
|
|
Feb 03
2022
|
Donald Notman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+40.5%
|
-
|
|
Jan 28
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
4,023
+0.07%
|
$20,115
$5.2 P/Share
|
|
Jan 27
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
1,477
+0.03%
|
$7,385
$5.2 P/Share
|
|
Jan 24
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
44,400
+0.75%
|
$222,000
$5.31 P/Share
|
|
Jan 21
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
12,152
+0.21%
|
$60,760
$5.56 P/Share
|
|
Jan 20
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
17,948
+0.31%
|
$89,740
$5.7 P/Share
|
|
Jan 18
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
6,807
+0.12%
|
$40,842
$6.0 P/Share
|
|
Jan 14
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
33,193
+0.57%
|
$199,158
$6.03 P/Share
|
|
Jan 13
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.17%
|
$60,000
$6.2 P/Share
|